Modification of α-bungarotoxin and cholinergic ligand-binding properties of Torpedo acetylcholine receptor by a monoclonal anti-acetylcholine receptor antibody

M. Mihovilovic, David P Richman

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The interaction between acetylcholine receptor (AcChR) and monoclonal antibody (mab) 247G - whose binding is blocked by the presence of α-bungarotoxin (αBgTx) - leads, in the absence of αBgTx, to a maximum binding of 0.5 mabs/αBgTx-binding site and, in turn, produces a maximum of 50% inhibition of αBgTx binding. For the solubilized AcChR, this inhibition is the result of blockade by mab 247G of the kinetically resolved slow component of αBgTx binding. The presence of cholinergic ligands does not significantly inhibit mab binding to the AcChR. AcChR·mab 247G complexes bind d-[3H]tubocurarine and carbamyl[3H]choline with the same stoichiometry as for free AcChR. However, while the binding isotherms for the agonist remain unaltered, the dissociation constant of the antagonist for its high-affinity site increases at least 3 times and there is a decrease in the total number of high-affinity sites and a concomitant increase in the total number of low-affinity sites. These results indicate that the binding of mab 247G to the AcChR stabilizes a new conformational state of the molecule capable of binding cholinergic ligands and confirm previous reports indicating that the cholinergic binding site can be viewed as a region of overlapping cholinergic binding subsites.

Original languageEnglish (US)
Pages (from-to)15051-15059
Number of pages9
JournalJournal of Biological Chemistry
Volume259
Issue number24
StatePublished - 1984
Externally publishedYes

Fingerprint

Torpedo
Bungarotoxins
Cholinergic Receptors
Cholinergic Agents
Ligands
Monoclonal Antibodies
Antibodies
Binding Sites
Tubocurarine
Choline
Stoichiometry
Isotherms
Molecules

ASJC Scopus subject areas

  • Biochemistry

Cite this

@article{969904d94b024a0db2833a099b6ce84e,
title = "Modification of α-bungarotoxin and cholinergic ligand-binding properties of Torpedo acetylcholine receptor by a monoclonal anti-acetylcholine receptor antibody",
abstract = "The interaction between acetylcholine receptor (AcChR) and monoclonal antibody (mab) 247G - whose binding is blocked by the presence of α-bungarotoxin (αBgTx) - leads, in the absence of αBgTx, to a maximum binding of 0.5 mabs/αBgTx-binding site and, in turn, produces a maximum of 50{\%} inhibition of αBgTx binding. For the solubilized AcChR, this inhibition is the result of blockade by mab 247G of the kinetically resolved slow component of αBgTx binding. The presence of cholinergic ligands does not significantly inhibit mab binding to the AcChR. AcChR·mab 247G complexes bind d-[3H]tubocurarine and carbamyl[3H]choline with the same stoichiometry as for free AcChR. However, while the binding isotherms for the agonist remain unaltered, the dissociation constant of the antagonist for its high-affinity site increases at least 3 times and there is a decrease in the total number of high-affinity sites and a concomitant increase in the total number of low-affinity sites. These results indicate that the binding of mab 247G to the AcChR stabilizes a new conformational state of the molecule capable of binding cholinergic ligands and confirm previous reports indicating that the cholinergic binding site can be viewed as a region of overlapping cholinergic binding subsites.",
author = "M. Mihovilovic and Richman, {David P}",
year = "1984",
language = "English (US)",
volume = "259",
pages = "15051--15059",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "24",

}

TY - JOUR

T1 - Modification of α-bungarotoxin and cholinergic ligand-binding properties of Torpedo acetylcholine receptor by a monoclonal anti-acetylcholine receptor antibody

AU - Mihovilovic, M.

AU - Richman, David P

PY - 1984

Y1 - 1984

N2 - The interaction between acetylcholine receptor (AcChR) and monoclonal antibody (mab) 247G - whose binding is blocked by the presence of α-bungarotoxin (αBgTx) - leads, in the absence of αBgTx, to a maximum binding of 0.5 mabs/αBgTx-binding site and, in turn, produces a maximum of 50% inhibition of αBgTx binding. For the solubilized AcChR, this inhibition is the result of blockade by mab 247G of the kinetically resolved slow component of αBgTx binding. The presence of cholinergic ligands does not significantly inhibit mab binding to the AcChR. AcChR·mab 247G complexes bind d-[3H]tubocurarine and carbamyl[3H]choline with the same stoichiometry as for free AcChR. However, while the binding isotherms for the agonist remain unaltered, the dissociation constant of the antagonist for its high-affinity site increases at least 3 times and there is a decrease in the total number of high-affinity sites and a concomitant increase in the total number of low-affinity sites. These results indicate that the binding of mab 247G to the AcChR stabilizes a new conformational state of the molecule capable of binding cholinergic ligands and confirm previous reports indicating that the cholinergic binding site can be viewed as a region of overlapping cholinergic binding subsites.

AB - The interaction between acetylcholine receptor (AcChR) and monoclonal antibody (mab) 247G - whose binding is blocked by the presence of α-bungarotoxin (αBgTx) - leads, in the absence of αBgTx, to a maximum binding of 0.5 mabs/αBgTx-binding site and, in turn, produces a maximum of 50% inhibition of αBgTx binding. For the solubilized AcChR, this inhibition is the result of blockade by mab 247G of the kinetically resolved slow component of αBgTx binding. The presence of cholinergic ligands does not significantly inhibit mab binding to the AcChR. AcChR·mab 247G complexes bind d-[3H]tubocurarine and carbamyl[3H]choline with the same stoichiometry as for free AcChR. However, while the binding isotherms for the agonist remain unaltered, the dissociation constant of the antagonist for its high-affinity site increases at least 3 times and there is a decrease in the total number of high-affinity sites and a concomitant increase in the total number of low-affinity sites. These results indicate that the binding of mab 247G to the AcChR stabilizes a new conformational state of the molecule capable of binding cholinergic ligands and confirm previous reports indicating that the cholinergic binding site can be viewed as a region of overlapping cholinergic binding subsites.

UR - http://www.scopus.com/inward/record.url?scp=0021686975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021686975&partnerID=8YFLogxK

M3 - Article

C2 - 6511786

AN - SCOPUS:0021686975

VL - 259

SP - 15051

EP - 15059

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 24

ER -